TXNIP and neuroblastoma: In our model of neuroblastoma MSN cells, we found a basal TXNIP expression that is reduced by around 10% by the shRNA against Txnip. Probably this decrease contributes to a reduction in TXNIP levels in response to treatment with staurosporine.